This compound is a chemical compound used as a pharmaceutical intermediate. Its structure includes multiple aromatic rings, an ester group, and ether linkages, contributing to its role in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 147403-52-9
Ethyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
pharmaceutical intermediate
Azilsartan
active pharmaceutical ingredient
Azilsartan
active pharmaceutical ingredient
Methyl 2-Ethoxy-1-[[2'-(hydroxyamidino)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
Azilsartan intermediate
T-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate
Pharmaceutical intermediate for pitavastatin
(R)-1-phenylethanamine (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
Pharmaceutical intermediate
Tert-butyl 4-(methylamino)piperidine-1-carboxylate
pharmaceutical intermediate
Azilsartan D5
active pharmaceutical ingredient
methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
PCMXVTVLQVGYLX-UHFFFAOYSA-N
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OC